1[1]Stenvinkel P,Lonnqvist F,Schalling M.Molecular studies of leptin:implications for renal disease.Nephrol Dial Transplant 1999; 14:1103-1112
2[2]Tartaglia LA,Dembski M,Weng X,Deng N,Culpepper J,Devos R,Richards GJ,Campfield LA,Clark FT,Deeds J,Muir C,Sanker S,Moriarty A,Moore KJ,Smutko JS,Mays GG,Wool EA,Monroe CA,Tepper RI.Identification and expression cloning of a leptin receptor,OB-R.Cell 1995; 83:1263-1271
3[3]Lammert A,Kiess W,Bottner A,Glasow A,Kratzsch J.Soluble leptin receptor represents the main leptin binding activity in human blood.Biochem Biophys Res Commun 2001; 283:982-988
4[4]Lahlou N,Clement K,Carel JC,Vaisse C,Lotton C,Le Bihan Y,Basdevant A,Lebouc Y,Froguel P,Roger M,Guy-Grand B.Soluble leptin receptor in serum of subjects with complete resistance to leptin:relation to fat mass.Diabetes 2000; 49:1347-1352
5[5]Angulo P.Nonalcoholic fatty liver disease.N Engl J Med 2002;346:1221-1231
6[6]Sheth SG,Gordon FD,Chopra S.Nonalcoholic steatohepatitis.Ann Intern Med 1997; 126:137-145
6Marchesim C, Brizi M, Bianehi G, et al. Nonalcoholic fatty liver dis- ease :a feature of the metabolic Syndrome[J]. Diabetes,2001,50(8) : 1844 - 1850.
7Adinolfi LE, Gambardella M, Andreana A, et al. Steatosis accelerates the progression of liver damage of chronic hepatitis C patients and correlates with specific HCV genotype and visceral obesity. Hepatology ,2001,33(6) :1358-1364.
8Yang Q, Graham TE, Mody N, et al. Serum retinol binding protein 4 contributes to insulin resistance in obesity and type 2 diabetes. Nature ,2005,436 (7049) :356-362.
9Graham TE, Yang Q, Bltiher M, et al. Retinol-binding protein 4 and insulin resistance in lean, obese, and diabetic subjects. N Engl J Med,2006,354(24) :2552-2563.
10Cho YM,Youn BS, Lee H, et al. Plasma retinol-binding protein-4 concentrations are elevated in human subjects with impaired glucose tolerance and type 2 diabetes. Diabetes Care ,2006,29( 11 ) :2457- 2461.
